One-Shot hope for fading facial scars

NCT ID NCT07474467

Summary

This early-stage study is testing a single injection called TRTP-101 to see if it is safe and can improve the appearance of acne scars. About 31 adults with noticeable acne scars on both sides of their face will participate. Researchers will inject the treatment on one side of the face and a placebo (inactive substance) on the other to compare results over 24 weeks.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ATROPHIC SCAR are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Samsung Medical Center

    Seoul, South Korea

Conditions

Explore the condition pages connected to this study.